Søren Schou Olesen
Søren Schou Olesen is an expert in Gastroenterology at Aalborg University Hospital (Denmark). As of October 2026, ScienceLeadR ranks Søren Schou Olesen in the top 1% of experts worldwide for Pancreatitis, Pancreatic Diseases and Pain. Søren Schou Olesen has authored 342 publications, the most recent in 2026, and is an investigator in 13 clinical trials, 4 of them ongoing. SLR score: 1,249 (community average: 125). How the SLR is computed.
LeadR Profile
Gastroenterology
Subspecialties: Hepatology - Endocrinology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 342
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Reply to the Letter to the Editor regarding 'Amylase and lipase in alcohol-induced acute pancreatitis: time to rethink diagnostic thresholds?'. PMID 42907287 — lipase, amylases, pancreas, pancreatitis | Pancreatology | 2026 | 0 |
| Pain profiles in pancreatic cancer and chronic pancreatitis: a multicenter cross-sectional analysis. PMID 42798443 — quality of life, pancreatic neoplasms, pancreatitis, chronic, cross-sectional studies, pain, catastrophization, pain management, neoplasms, pancreatitis, hyperalgesia | Front Pain Res (Lausanne) | 2026 | 0 |
| Electrophysiological biomarkers for foundational signal markers in chronic pancreatitis using machine learning models. PMID 42558996 — support vector machine, pancreatitis, chronic, pain, classification, biomarkers, machine learning, electroencephalography, pancreatitis, learning, electrocardiography | Front Pain Res (Lausanne) | 2026 | 0 |
| Continuous Glucose Monitoring Data Compression Using Peak-Nadir Encoding in Diabetes: Method Development and Evaluation. PMID 42476102 — diabetes mellitus, data compression, continuous glucose monitoring | JMIR Biomed Eng | 2026 | 0 |
| Letter: Severity-Informed Enrichment for Recurrent Acute Pancreatitis Trials. Authors' Reply. PMID 42429305 — pancreatitis, pharmacology, therapeutics | Aliment Pharmacol Ther | 2026 | 0 |
Clinical Studies 13
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
4 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Tocilizumab for Painful Chronic Pancreatitis (TOPAC trial) 2023-510084-35-00 — pancreatitis, chronic, pancreatitis | Phase 2 | Recruiting | 2024 |
| Tocilizumab for Painful Chronic Pancreatitis NCT06426160 — pancreatitis, chronic, digestive system diseases, pancreatitis, digestive system, pancreatic diseases | Phase 2 | Active not recruiting | 2024 |
| Pancreatic Quantitative Sensory Testing (P QST) to Predict Treatment Response for Pain in Chronic Pancreatitis NCT04996628 — cholangiopancreatography, endoscopic retrograde, research design, pancreatitis, chronic, chronic pain, pain, postsynaptic potential summation, pain measurement, baths, pancreatitis, therapeutics, ice, abdominal pain | N/A | Recruiting | 2022 |
| Effects of a Peripherally Acting opioid Receptor Antagonist on Recurrent Acute Pancreatitis NCT04966559 — narcotic antagonists, pharmaceutical preparations, tablets, pancreatitis, receptors, opioid, therapeutics | Phase 2/Phase 3 | Active not recruiting | 2022 |
LeadR Networks
Main global connection map